Skip to main content
Have a personal or library account? Click to login
Postoperative radiochemotherapy for gastric adenocarcinoma: long term results Cover

Postoperative radiochemotherapy for gastric adenocarcinoma: long term results

Open Access
|Oct 2009

References

  1. Gunderson LL, Burch PA, Donohue JH. The Role of Irradiation as a Component of Combined Modality Treatment for Gastric Carcinoma.1995; 5: 117-24.
  2. Gunderson LL, Sosin H. Adenocarcinoma of the stomach: Areas of failure in a reoperation series (second or symptomatic look) clinicopathological correlation and implications for adjuvant therapy.1982; 8: 1-11.
  3. Smalley SR, Gunderson L, Tepper J, Martenson JA Jr, Minsky B, Willett C, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation.2002; 52: 283-93.
  4. Willett CG, Gunderson LL. Stomach. In: Perez CA, Brady LW, editors.Philadelphia: Lippincott-Raven Publishers; 2008. p. 1318-35.
  5. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.2001; 345: 725-30.
  6. Bora H, Unsal D, Akmansu M. Results of chemoirradiation after curative resection of locally advanced gastric cancer.2004; 58: 451-6.
  7. Moertel CG, Childs DS, O'Fallon JR, Holbrook MA, Schutt AJ, Reitemeier RJ. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma.1984; 2: 1249-54.
  8. Hughes BG, Yip D, Chao M, Gibbs P, Carroll S, Goldstein D, et al. Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience.2004; 74: 951-6.
  9. Park SH, Kim DY, Heo JS, Lim DH, Park CK, Lee KW, et al. Postoperative chemotherapy for gastric cancer.2003; 14: 1373-7.
  10. Oblak I, Velenik V, Anderluh F, Strojan P. Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia.2007; 33: 982-7.
  11. Surenkok S, Beyzadeoglu M, Oysul K, Ozyigit G, Ataergin S, Arpaci F, et al. The management of gastric adenocarcinoma with postoperative chemoirradiation. A non-randomized comparison of oral UFT and 5-FU.2008; 94: 70-4.
  12. Oechsle K, Bokemeyer C, Hartmann JT, Budach W, Trarbach T, Stahl M, et al. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group.2009; 135: 163-72.
  13. Baeza MR, Giannini TO, Rivera SR, Gonzalez P, Gonzalez J, Vergara E, et al. Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer.2001; 50: 645-50.
  14. Beşe NS, Büyükünal E, Özgüro lu M, Demir G, Yildirim A, Mandel NM, et al. Toxicity and survival results of a phase II study investigating the role of postoperative chemoradioimmunotherapy for gastric adenocarcinoma.2005; 181: 652-9.
  15. Bleiberg H, Goffin JC, Dalesio O, Buyse M, Pector JC, Gignoux M, et al. Adjuvant radiotherapy and chemotherapy in resectable gastric cancer: A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC.1989; 15: 535-43.
  16. Lim DH, Kim DY, Kang MK, Kim YI, Kang WK, Park CK, et al. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncology's view.2004; 91: 11-7.
  17. Earle CC, Maroun J, Zuraw L; Cancer Care Ontario Practice Guidelines Initiative Gastrointestinal Cancer Disease Site Group. Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline.2002; 45: 438-46.
  18. Jansen EP, Saunders MP, Boot H, Oppedijk V, Dubbelman R, Porritt B, et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer.2007; 67: 781-5.
  19. Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH. Comprehensive criteria for assessing therapy-induced toxicity.1990; 8: 147-59
  20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.1958; 53: 457-81.
  21. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples.1977; 35: 1-39.
  22. Cox DR. Regression models and life-tables.1972; 34: 187-220.
  23. MacDonald JS. Role of post-operative chemoradiation in resected gastric cancer.2005; 90: 166-70.
  24. Kovač V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer.2004; 51: 334-40.
  25. Debevec L, Jerič T, Kovač V, Bitenc M, Sok M. Is there any progress in routine management of lung cancer patients? A comparative analysis of an institution in 1996 and 2006.2009; 43: 47-53.
  26. Yao JC, Mansfield PF, Pisters PW, Feig BW, Janjan NA, Crane C, et al. Combined-modality therapy for gastric cancer.2003; 21: 223-7.
  27. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer.1998; 1: 125-33.
  28. DeVita VT Jr, Chu E. Principles of Medical Oncology. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, editors.Philadelphia: Lippincott Williams and Wilkins; 2008. p. 337-50.
  29. Kragelj B. Increased late urinary toxicity with whole pelvic radiotherapy after prostatectomy.2009; 43: 88-96.
  30. Stavrev P, Schinkel C, Stavreva N, Fallone BG. How well are clinical gross tumor volume DVHs approximated by an analytical function?2009; 43: 132-5.
  31. Velenik V. Locally recurrent rectal cancer: treatment options.2009; 43: 144-51.
DOI: https://doi.org/10.2478/v10019-009-0035-7 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 274 - 281
Published on: Oct 26, 2009
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2009 Irena Oblak, Franc Anderluh, Vaneja Velenik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.